Immunocore Holdings Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +79.6% | +43.7% | -12.2% | +63.7% | +8.5% | +17.3% | -10.2% | +433.3% | +36.9% | +25.6% | +20.0% | |
| – | – | – | – | – | – | -25.2% | -0.9% | -92.9% | -84.5% | +575.6% | +12.1% | |
| – | +79.6% | +43.7% | -12.2% | +63.7% | -414.2% | – | – | +413.7% | +41.5% | +23.3% | +20.2% | |
| – | +81.3% | +108.0% | +32.9% | +36.7% | +19.6% | -25.2% | -0.7% | +13.5% | +53.5% | +37.1% | +15.2% | |
| – | +20.8% | +25.5% | +487.8% | +55.1% | +29.4% | +3.5% | +160.8% | -21.4% | +65.2% | +0.6% | +6.2% | |
| – | +83.5% | +94.9% | +69.3% | +42.1% | -62.6% | -5.7% | +277.0% | +16.1% | +34.1% | +22.6% | +8.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +350.8% | -18.1% | +79.3% | -2.9% | -24.6% | +362.0% | -35.4% | |
| – | – | -316.5% | – | – | – | – | – | – | – | – | – | |
| – | -39.8% | +741.4% | +95.7% | -204.6% | – | -159.6% | – | +8,574.6% | -146.0% | – | – | |
| – | – | -271.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.